Page last updated: 2024-08-21

nandrolone and Endometrioma

nandrolone has been researched along with Endometrioma in 168 studies

Research

Studies (168)

Timeframe	Studies, this research(%)	All Research%
pre-1990	12 (7.14)	18.7374
1990's	7 (4.17)	18.2507
2000's	9 (5.36)	29.6817
2010's	97 (57.74)	24.3611
2020's	43 (25.60)	2.80

Authors

Authors	Studies
Lee, SM; Park, JK	1
Ebrahimpour, M; Mehdizadeh Kashi, A; Niakan, G; Rokhgireh, S	1
Abbasi, S; Abu Musa, A; El Taha, L; Khalifeh, D; Khalil, A; Nassif, J	1
Goto, M; Iwase, A; Kajiyama, H; Miyake, N; Murakami, M; Muraoka, A; Nakamura, T; Nakanishi, N; Osuka, S; Sonehara, R; Tanaka, H; Yabuki, A; Yoshihara, M; Yoshita, S	1
Banal-Silao, MJ; Cai, L; Hestiantoro, A; Hidayat, ST; Kim, MR; Lee, BS; Seong, SJ; Shin, S; Soon, R; Techatraisak, K	1
Engin-Ustun, Y; Ibanoglu, MC; Kıykac Altinbas, S; Kizilkaya, Y	1
Duffy, JMN; Farquhar, CM; Hirsch, M	1
Allahqoli, L; Ebrahimpour, M; Hassanlouei, B; Niakan, G	1
Caruso, G; Caruso, S; Cianci, A; Cianci, S; Iraci Sareri, M; Panella, M	1
Choi, D; Choi, SH; Kim, SE; Lee, DY; Lim, HH	1
Li, Z; Wang, L; Wang, X; Zhang, Z	1
Kadirogullari, P; Seckin, KD	1
Alfano, P; Audino, P; Incandela, D; Maiorana, A; Marcantonio, S; Mercurio, A; Minneci, G	1
Li, X; Lin, J; Liu, Y; Zhang, L	1
Akimoto, Y; Honda, H; Kaneko, M; Nishimichi, N; Tanimoto, H; Teramoto, H; Teramoto, M; Yamashita, M; Yokosaki, Y	1
Tang, M; Yang, W; Zhang, H	1
Hosseini, L; Hosseini, R; Rastad, H; Rodi, H; Vahid-Dastjerdi, M	1
Dietrich, H; Imesch, P; Knobel, C; Merki-Feld, GS; Metzler, J; Muendane, A; Neumeier, MS; Niggli, A; Portmann, L	1
Bogani, G; Carbone, F; Di Donato, V; Di Tucci, C; Galati, G; Kontopantelis, E; Muzii, L; Palaia, I; Perniola, G; Tomao, F	1
Arena, A; Aru, AC; Borghese, G; Caroli, M; Casadio, P; Del Forno, S; Lenzi, J; Meriggiola, MC; Orsini, B; Paradisi, R; Raimondo, D; Seracchioli, R; Verrelli, L	1
Bardhi, E; Boccia, SM; Musella, A; Palaia, I; Panici, PB; Pecorini, F	1
Fujimoto, A; Honda, M; Isono, W; Matsuyama, R; Nishii, O; Saito, A; Tsuchiya, A; Tsuchiya, H	1
Choi, D; Choi, J; Jo, M; Lee, DY; Lee, E	2
Hudeček, R; Papíková, Z; Szypulová, M; Ventruba, P	1
Josaki, M; Kikuchi, H; Mihara, Y; Shinagawa, M; Shirafuta, Y; Sugino, N; Takasaki, A; Taketani, T; Tamura, H; Tamura, I; Yoshida, H	1
Fukui, Y; Hashimoto, T; Hayashi, T; Hirota, Y; Ikemura, M; Inoue, S; Kawazu, M; Kiyono, T; Kojima, S; Mano, H; Muraoka, A; Oda, K; Osuga, Y; Osuka, S; Saito, T; Sakata, S; Taguchi, A; Takeuchi, K; Takeyama, R; Tanaka, T; Tanaka, Y; Terao, Y; Ueno, T; Yoshida, E	1
Cho, B; Cho, CH; Jeong, K; Kim, SH; Kim, TH; Kim, YS; Kwon, YS; Park, J; Park, SH; Roh, JW	1
Angioni, S; Barbasetti Di Prun, A; Barbera, V; Belloni, GM; Pietropaolo, G; Pino, I; Vignali, M	1
Biberoğlu, K; Leng, J; Mueller, MD; Murji, A; Römer, T; Vignali, M; Yarmolinskaya, M	1
Becker, K; Faustmann, T; Gerlinger, C; Heinemann, K; Imthurn, B; Marions, L; Moehner, S	1
Abdelhakim, AM; Ahmed, SA; AlAmodi, AA; Ali, AS; Ashour, K; El Kattan, EAM; Elsherbini, M; Fathi, M; Haggag, H; Keshta, NHA; Salah, DM; Samy, A; Shareef, MA; Shatat, HBAE; Sileem, SA; Taher, A	1
Becker, K; Heinemann, K; Lange, JA; Moehner, S; von Stockum, S	1
Ikuma, S; Jinushi, M; Kawasaki, Y; Kitade, M; Kumakiri, J; Murakami, K; Ozaki, R	1
Nickisch, K; Oettel, M; Zentel, HJ	1
Agliati, L; Gasparri, ML; McKinnon, B; Mueller, MD; Nirgianakis, K; Vaineau, C	1
Barra, F; Ferrero, S; Garzon, S; Ghezzi, F; Laganà, AS; Scala, C	1
Iwami, N; Kamiya, H; Kawamata, M; Mizuuchi, M; Moriwaka, O; Ozawa, N; Watanabe, E; Yamamoto, T	1
Fukutomi, T; Kobayashi, Y; Mita, S; Suzuki, A; Watanabe, M	1
Choi, D; Kim, SE; Lee, DY; Lim, HH	1
Asano, R; Miyagi, E; Nagai, K; Nakamura, T; Ono, N; Sugo, Y	1
Aygen, EM; Demirtas, E; Sahin, Y; Uludag, SZ	1
Alkatout, I; Allahqoli, L; Ebrahimpour, M; Gitas, G; Hassanlouei, B; Mehdizadeh Kashi, A; Niakan, G	1
Abdel-Rasheed, M; Abdullah, A; Hosni, M; Khairy, M; Khalifa, E; Mohammad, H	1
Ceccarello, M; Ceccaroni, M; Clarizia, R; Donati, A; Ferrero, S; Liverani, S; Manzone, M; Roviglione, G	1
Fukami, T; Matsushima, T; Shinmura, H; Takeshita, T	1
Dai, Y; Duan, J; Ha, C; Huang, R; Huang, X; Liu, J; Qiu, Y; Shi, B; Xiao, D; Xuan, J	1
Choi, D; Lee, DY; Seo, JW; Yoon, BK	1
Bersinger, NA; Facchinetti, F; Grandi, G; McKinnon, BD; Mueller, MD	1
Baldane, S; Celik, C; Dursunoglu, D; Ilhan, TT; Ipekci, SH; Kebapcilar, AG; Kebapcilar, L; Kirac, CO; Kurt, K; Ucar, MG	1
Hashiba, M; Ichioka, M; Kyo, S; Mita, S; Miyazaki, H; Nakakuki, M; Shimizu, Y	1
Ban Frangež, H; Chiofalo, B; Granese, R; Laganà, AS; Palmara, V; Triolo, O; Vitale, SG; Vrtačnik-Bokal, E	1
Alio, L; Alio, W; Giambanco, L; Incandela, D; Maiorana, A; Mercurio, A; Parazzini, F	1
Andou, M; Ebisawa, K; Hada, T; Kanno, K; Matsumoto, T; Nakajima, S; Ota, Y; Shirane, A; Yamanaka, A; Yanai, S	1
Dong, L; Gude, K; Lang, J; Li, H; Ren, X; von Ludwig, C; Yu, Q; Zhang, S	1
Arena, A; Caprara, G; Del Forno, S; Mabrouk, M; Matteucci, C; Paradisi, R; Seracchioli, R; Zannoni, L	1
Cho, S; Kim, SH; Lee, DY; Lee, SR; Seo, SK; Song, JY; Yi, KW	1
Aylamazyan, E; Gzgzyan, A; Kogan, I; Muller, V; Niauri, D; Yarmolinskaya, M	1
Kamada, Y; Kotani, S; Masuyama, H; Sakamoto, A	1
Chabbert-Buffet, N; Fernandez, H; Geoffron, S; Legendre, G; Sauvan, M; Wattier, JM	1
Bouet, PE; Chabbert-Buffet, N; Delbos, L; Descamps, P; Fernandez, H; Geoffron, S; Hudon, E; Legendre, G; Sauvan, M	1
Cheung, CW; Fung, WY; Liang, B; Wang, CC; Wong, SW; Wu, L; Xu, H	1
Caserta, D; Maniglio, P; Meli, F; Peiretti, M; Ricciardi, E; Tomao, F	1
Jee, BC; Jeong, SH; Kim, SK; Lee, D	1
Angerame Yela, D; Laguna Benetti-Pinto, C; Paulo Leonardo-Pinto, J	1
Cho, S; Kim, SH; Lee, DY; Lee, JH; Lee, SR; Seo, SK; Shin, JH; Song, JY; Yi, KW	1
Han, HY; Jung, YW; Kang, BH; Ko, YB; Lee, KH; Lee, M; Song, SY; Yang, JB; Yoo, HJ	1
Akiyama, K; Ito, F; Kataoka, H; Kitawaki, J; Koshiba, A; Kusuki, I; Matsushima, H; Mori, T; Okimura, H; Takaoka, O	1
Herrmann, J; Kochhar, PS; Markert, UR; Morales-Prieto, DM; Oettel, M; Osterwald, H; Schleussner, E	1
Römer, T	1
Hiramatsu, T; Hongo, K; Kazama, S; Kuriki, K; Kuroda, K; Tanaka, T; Watanabe, Y	1
Dong, L; Lang, J; Li, H; Ren, X; Wang, P; Yu, Q; Zhang, S; Zvolanek, M	1
Awaga, Y; Hama, A; Hayashi, I; Matsuda, A; Natsume, T; Ogawa, S; Takamatsu, H; Yano, M	1
Choi, D; Kim, SE; Lee, DY; Seo, JW; Yoon, BK	1
Dashraath, P; Kailun, C; Li, M	1
Ahlers, C; Banal-Silao, MJ; Hestiantoro, A; Kim, MR; Lee, BS; Ruey, S; Seong, SJ; Shin, SY; Techatraisak, K; Thaufik, S	1
Arena, A; Del Forno, S; Giaquinto, I; Mabrouk, M; Mattioli, G; Paradisi, R; Seracchioli, R	1
Angioni, S; Cela, V; Litta, P; Luisi, S; Malune, ME; Nappi, L; Pontis, A; Vignali, M	1
Arakawa, T; Fujii, T; Fukuda, S; Harada, M; Hirata, T; Hirota, Y; Koga, K; Ma, S; Nagashima, N; Neriishi, K; Osuga, Y; Sun, H; Wada-Hiraike, O	1
Mocciaro, R; Morelli, M; Sacchinelli, A; Venturella, R; Zullo, F	1
Calagna, G; Colacurci, N; Cucinella, G; De Franciscis, P; Granese, R; Perino, A; Saitta, S; Svelato, A; Tonni, G	1
Akita, M; Brosens, JJ; Fujita, K; Ishihara, O; Kajihara, T; Matsumoto, S; Nagashima, M; Prechapanich, J; Sato, K; Tanaka, K; Uchino, S	1
Avraham, S; Seidman, DS	1
Fukaya, T; Izumiya, C; Maeda, N; Matsushima, S; Mita, S; Shimizu, Y; Taniguchi, K	1
Fujii, T; Harada, M; Hirata, T; Hirota, Y; Izumi, G; Koga, K; Miyashita, M; Nagai, M; Osuga, Y; Takamura, M	1
Iwasaki, M; Matsuura, M; Saito, T; Tabuchi, Y; Takada, S; Tamate, M; Tanaka, R	1
Kurabayashi, T; Tamura, M; Tsuneki, I; Yanase, T	1
Bizzarri, N; Candiani, M; Ferrero, S; Ghirardi, V; Leone Roberti Maggiore, U; Remorgida, V; Salvatore, S; Scala, C; Tafi, E; Venturini, PL	1
Guvenal, T; Hasdemir, PS; Ikiz, N; Kara, E; Ozcakir, HT	1
Ferrero, S; Leone Roberti Maggiore, U; Salvatore, S	1
Hayashi, A; Hayashi, M; Kyo, S; Ohmichi, M; Ono, YJ; Tanabe, A; Terai, Y; Yamashita, Y	1
Agarwal, S; Chen, I; Fraser, MA; Singh, SS	1
Cagnacci, A; Grandi, G; Napolitano, A; Palma, F; Xholli, A	1
Ferrero, S; Morotti, M; Remorgida, V; Sozzi, F; Venturini, PL	1
Bono, Y; Ichioka, M; Imada, K; Kiyono, T; Kyo, S; Mita, S; Shimizu, Y	1
Andres, Mde P; Baracat, EC; Lopes, LA; Podgaec, S	1
Calagna, G; Colacurci, N; Cucinella, G; De Franciscis, P; Granese, R; Perino, A; Saitta, S; Triolo, O	1
Ito, F; Kitawaki, J; Koshiba, A; Kusuki, I; Matsushima, H; Mori, T; Takaoka, O; Tanaka, Y	1
Angioni, S; Luisi, S; Mais, V; Melis, GB; Nappi, L; Pontis, A; Sedda, F	1
Hatano, K; Hiraku, Y; Morishige, K; Sato, K; Shibata, M; Takenaka, M; Yamamoto, K; Yamamoto, S; Yano, R	1
Fawzy, M; Mesbah, Y	1
Bizzarri, N; Ferrero, S; Remorgida, V; Venturini, PL	1
Caruso, S; Casella, E; Cianci, A; Cianci, S; Fava, V; Iraci, M	2
Hayashi, H; Nagata, C; Okamoto, A; Sugimoto, K; Yanagida, S	1
Bersinger, NA; Cagnacci, A; Grandi, G; McKinnon, B; Mueller, M; Volpe, A	1
Alberico, D; Bracco, B; Dhouha, D; Mosconi, P; Roberto, A; Somigliana, E; Vercellini, P	1
Adachi, K; Fujitani, M; Kimura, T; Kobayashi, E; Miyoshi, Y; Nakamura, K; Otake, A; Sasamoto, N; Sawada, K; Shioji, M; Takahashi, K; Tokuhira, A; Wakimoto, A; Yamamoto, Y; Yoshimura, A	1
Isaka, K; Kato, R; Kojima, J; Nagamitsu, Y; Nishi, H; Sasaki, T; Takaesu, Y	1
Ani Amelia, Z; Chew, KT; Hing, EY; Nor Azlin, MI; Norsaadah, S; Nur Azurah, AG; Suraya, A	1
Bersinger, N; Cagnacci, A; Grandi, G; McKinnon, B; Mueller, M; Nirgianakis, K	1
Bersinger, N; Cagnacci, A; Grandi, G; McKinnon, B; Mueller, M; Nirgianakis, K; Papadia, A	1
Choi, D; Lee, DY; Lee, JY; Seo, JW; Yoon, BK	1
Alfaraj, S; Allaire, C; Bedaiwy, MA	1
Casper, RF	1
Böttcher, B; Dong, L; Ebert, AD; Francuski, M; Gude, K; Hlavackova, O; Kirsch, B; Merz, M; Roman, H; Seitz, C; Suvitie, P	1
Benetti-Pinto, CL; Cursino, K; Leonardo-Pinto, JP; Yela, DA	1
Aso, T; Fukunaga, M; Hagino, H; Harada, T; Momoeda, M; Taketani, Y; Terakawa, N	2
Imada, K; Mizuguchi, K; Sasagawa, S; Shimizu, Y	1
Christensen, B; Henkel, A; Moore, C; Oettel, M; Schindler, AE	2
Faustmann, TA; Gerlinger, C; Köhler, G; Mueck, AO; Seitz, C	1
Harada, T; Taniguchi, F	1
Henkel, A; Moore, C; Oettel, M; Schindler, AE	1
Kitawaki, J	1
Faustmann, T; Gerlinger, C; Marr, J; Seitz, C; Strowitzki, T	2
Faustmann, T; Gerlinger, C; Seitz, C; Strowitzki, T	1
Hiratsuka, M; Ito, M; Katayama, H; Katayama, T; Kiyomura, M; Shimizu, Y; Sugita, A; Uematsu, K	1
McCormack, PL	1
Ichigo, S; Imai, A; Matsunami, K; Suzuki, N; Takagi, H	1
Harada, M; Hirata, T; Izumi, G; Koga, K; Osuga, Y; Takamura, M; Takemura, Y; Taketani, Y; Yano, T; Yoshino, O	1
Kitawaki, J; Kusuki, I; Suganuma, I; Yamanaka, K	1
Faustmann, T; Gerlinger, C; Hornung, D; Lazzeri, L; Luisi, S; Petraglia, F; Seitz, C; Strowitzki, T	1
Ichigo, S; Imai, A; Matsunami, K; Takagi, H	1
Fischer, OM; Fuhrmann, U; Kaufmann-Reiche, U; Moeller, C	1
Kitawaki, J; Kusuki, I; Mita, S; Mizuguchi, K; Shimizu, Y; Suganuma, I; Xu, B; Yamanaka, K	1
Mueck, AO; Ruan, X; Seeger, H	1
Morikawa, A; Nagata, C; Ochiai, K; Okamoto, A; Okamoto, S; Sugimoto, K; Tanaka, T; Yanagida, S	1
Faustmann, T; Gerlinger, C; Hassall, JJ; Seitz, C	1
Beranič, N; Rižner, TL	1
Beranič, N; Lanišnik Rižner, T	1
GAUTIER, P	1
HELPAP, B	1
ANTOINE, T	1
TOTH, F	1
KAISER, R	1
MCGARRITY, KA	1
Fu, L; Hirata, T; Hirota, Y; Morimoto, C; Osuga, Y; Taketani, Y; Yano, T	1
MacDonald, HM	1
Maartens, R	1
Aoki, D; Katsuki, Y; Nozawa, S; Sasagawa, S; Shibutani, Y; Takano, Y; Udagawa, Y	1
Aoki, D; Futamura, Y; Katsuki, Y; Nozawa, S; Shibutani, Y; Takano, Y; Udagawa, Y	1
Cline, JM; Obasanjo, IO; Schmotzer, S; Weaver, DS	1
Christensen, B; Henkel, A; Schindler, AE	1
Fiegler, P; Kamiński, K; Marr, J; Moore, C	1
Fiegler, P; Gabryś, J; Kamiński, K; Kozielski, J	1
Audebert, A; Cosson, M; Donnez, J; Konincks, P; Madelenat, P; Manhes, H; Querleu, D	1
Buchmann, J; Kaltwasser, P; Rothe, K; Schneider, F; Seliger, E	1
Brachmann, K; Göretzlehner, G; Köhler, G	1
Köhler, G; Männchen, E; Nikschick, S	1
Brachmann, K; Foth, D; Happke, S; Köhler, G; Lembke, S	1
Amon, I; Göretzlehner, G; Köhler, G	1
Alicino, R; Borsò, N	1
Bernard, I	1

Reviews

20 review(s) available for nandrolone and Endometrioma

Article	Year
Pretreatment of Dienogest for Women with Endometriosis in in vitro Fertilization: A Systematic Review and Meta-Analysis. Gynecologic and obstetric investigation, 2023, Volume: 88, Issue:3 Topics: Endometriosis; Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Humans; Nandrolone; Ovulation Induction; Pregnancy; Pregnancy Rate	2023
The Efficacy of Dienogest in Reducing Disease and Pain Recurrence After Endometriosis Surgery: a Systematic Review and Meta-Analysis. Reproductive sciences (Thousand Oaks, Calif.), 2023, Volume: 30, Issue:11 Topics: Cysts; Endometriosis; Female; Hot Flashes; Humans; Nandrolone; Pelvic Pain; Progestins	2023
Use of dienogest in endometriosis: a narrative literature review and expert commentary. Current medical research and opinion, 2020, Volume: 36, Issue:5 Topics: Bone Density; Endometriosis; Female; Hormone Antagonists; Humans; Nandrolone	2020
Medical therapy options for endometriosis related pain, which is better? A systematic review and network meta-analysis of randomized controlled trials. Journal of gynecology obstetrics and human reproduction, 2021, Volume: 50, Issue:1 Topics: Contraceptive Agents, Hormonal; Contraceptives, Oral, Hormonal; Dysmenorrhea; Endometriosis; Female; Gonadotropin-Releasing Hormone; Humans; Hydrocarbons, Fluorinated; Levonorgestrel; Nandrolone; Network Meta-Analysis; Pelvic Pain; Pyrimidines; Randomized Controlled Trials as Topic; Visual Analog Scale	2021
A progestin isn't a progestin: dienogest for endometriosis as a blueprint for future research - Review as a contribution for discussion. Hormone molecular biology and clinical investigation, 2020, Jul-15, Volume: 42, Issue:2 Topics: Clinical Decision-Making; Contraceptives, Oral, Hormonal; Disease Management; Endometriosis; Female; Humans; Nandrolone; Progestins; Structure-Activity Relationship; Treatment Outcome	2020
[Management of painful endometriosis in adolescents: CNGOF-HAS Endometriosis Guidelines]. Gynecologie, obstetrique, fertilite & senologie, 2018, Volume: 46, Issue:3 Topics: Adolescent; Contraceptives, Oral; Endometriosis; Female; Gonadotropin-Releasing Hormone; Humans; Nandrolone; Pelvic Pain	2018
[New medical treatments for painful endometriosis: CNGOF-HAS Endometriosis Guidelines]. Gynecologie, obstetrique, fertilite & senologie, 2018, Volume: 46, Issue:3 Topics: Aromatase Inhibitors; Contraceptives, Oral; Dyspareunia; Endometriosis; Female; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Nandrolone; Pelvic Pain; Selective Estrogen Receptor Modulators	2018
Dienogest in the treatment of endometriosis. Expert opinion on pharmacotherapy, 2014, Volume: 15, Issue:13 Topics: Administration, Oral; Clinical Trials as Topic; Endometriosis; Female; Humans; Nandrolone; Progestins	2014
Dienogest for the treatment of deep endometriosis: case report and literature review. The journal of obstetrics and gynaecology research, 2015, Volume: 41, Issue:2 Topics: Adult; Endometriosis; Female; Hormone Antagonists; Humans; Nandrolone; Urinary Bladder Diseases; Vaginal Diseases	2015
Dienogest in the treatment of endometriosis: systematic review. Archives of gynecology and obstetrics, 2015, Volume: 292, Issue:3 Topics: Adult; Endometriosis; Female; Hormone Antagonists; Humans; Middle Aged; Nandrolone; Pelvic Pain; Progestins; Treatment Outcome	2015
Endometriosis: the effects of dienogest. BMJ clinical evidence, 2015, Jun-09, Volume: 2015 Topics: Endometriosis; Female; Humans; Nandrolone	2015
Does dienogest influence the inflammatory response of endometriotic cells? A systematic review. Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2016, Volume: 65, Issue:3 Topics: Animals; Cytokines; Endometriosis; Epithelial Cells; Female; Hormone Antagonists; Humans; Immunologic Factors; Intercellular Signaling Peptides and Proteins; Nandrolone; Prostaglandins; Stromal Cells	2016
Long-term medical management of endometriosis with dienogest and with a gonadotropin-releasing hormone agonist and add-back hormone therapy. Fertility and sterility, 2017, Volume: 107, Issue:3 Topics: Adolescent; Adult; Age Factors; Contraceptives, Oral, Combined; Cost-Benefit Analysis; Drug Costs; Drug Therapy, Combination; Endometriosis; Endometrium; Female; Gonadotropin-Releasing Hormone; Humans; Medication Adherence; Nandrolone; Pelvic Pain; Progestins; Recurrence; Treatment Outcome; Young Adult	2017
Progestin-only pills may be a better first-line treatment for endometriosis than combined estrogen-progestin contraceptive pills. Fertility and sterility, 2017, Volume: 107, Issue:3 Topics: Administration, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Endometriosis; Endometrium; Female; Humans; Menstrual Cycle; Nandrolone; Norethindrone; Norethindrone Acetate; Pelvic Pain; Progestins; Treatment Outcome	2017
[Pharmacological and clinical profile of dienogest (DINAGEST Tab. 1 mg)]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2009, Volume: 133, Issue:1 Topics: Animals; Endometriosis; Female; Hormone Antagonists; Humans; Macaca mulatta; Mice; Nandrolone; Progesterone Congeners; Rabbits; Uterine Diseases	2009
Dienogest: a new therapeutic agent for the treatment of endometriosis. Women's health (London, England), 2010, Volume: 6, Issue:1 Topics: Animals; Dysmenorrhea; Endometriosis; Female; Hormone Antagonists; Humans; Male; Nandrolone; Ovary; Rabbits; Randomized Controlled Trials as Topic; Treatment Outcome; Uterine Hemorrhage	2010
[Maintenance therapy for endometriosis]. Nihon rinsho. Japanese journal of clinical medicine, 2010, Volume: 68, Issue:1 Topics: Clinical Trials as Topic; Contraceptives, Oral; Danazol; Drug Therapy, Combination; Endometriosis; Estrogens; Female; Gonadotropin-Releasing Hormone; Gynecologic Surgical Procedures; Humans; Levonorgestrel; Nandrolone; Pelvic Pain; Progesterone Congeners	2010
Dienogest: a review of its use in the treatment of endometriosis. Drugs, 2010, Nov-12, Volume: 70, Issue:16 Topics: Animals; Endometriosis; Female; Humans; Nandrolone; Progestins	2010
The pharmacology of dienogest. Maturitas, 2012, Volume: 71, Issue:4 Topics: Contraceptives, Oral; Endometriosis; Endometrium; Female; Humans; Menstrual Cycle; Nandrolone; Progestins	2012
Treatment of endometriosis in different ethnic populations: a meta-analysis of two clinical trials. BMC women's health, 2012, Apr-19, Volume: 12 Topics: Asian People; Buserelin; Endometriosis; Europe; Female; Hormone Antagonists; Humans; Japan; Leuprolide; Nandrolone; Treatment Outcome; White People	2012

Trials

33 trial(s) available for nandrolone and Endometrioma

Article	Year
Comparing the Effect of Dienogest and OCPS on Pain and Quality of Life in Women with Endometriosis: A Randomized, Double-Blind, Placebo-Controlled Trial. Archives of Iranian medicine, 2021, 09-01, Volume: 24, Issue:9 Topics: Adult; Endometriosis; Female; Humans; Iran; Nandrolone; Pain Measurement; Pelvic Pain; Quality of Life; Treatment Outcome	2021
Efficacy of dienogest vs combined oral contraceptive on pain associated with endometriosis: Randomized clinical trial. European journal of obstetrics, gynecology, and reproductive biology, 2021, Volume: 267 Topics: Contraceptives, Oral, Combined; Endometriosis; Female; Humans; Nandrolone; Pelvic Pain; Quality of Life; Retrospective Studies	2021
Impact of perioperative use of GnRH agonist or dienogest on ovarian reserve after cystectomy for endometriomas: a randomized controlled trial. Reproductive biology and endocrinology : RB&E, 2021, Dec-06, Volume: 19, Issue:1 Topics: Adult; Cystectomy; Endometriosis; Female; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Laparoscopy; Nandrolone; Ovarian Reserve; Treatment Outcome; Urinary Bladder Diseases	2021
Re: A randomized, double-blind, placebo-controlled pilot study of the comparative effects of dienogest and the combined oral contraceptive pill in women with endometriosis. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2022, Volume: 158, Issue:1 Topics: Contraceptives, Oral, Combined; Double-Blind Method; Endometriosis; Female; Humans; Nandrolone; Pilot Projects	2022
Response: A randomized, double-blind, placebo-controlled pilot study of the comparative effects of dienogest and the combined oral contraceptive pill in women with endometriosis. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2022, Volume: 158, Issue:1 Topics: Contraceptives, Oral, Combined; Double-Blind Method; Endometriosis; Female; Humans; Nandrolone; Pilot Projects	2022
Randomized study on the effectiveness of nomegestrol acetate plus 17β-estradiol oral contraceptive versus dienogest oral pill in women with suspected endometriosis‑associated chronic pelvic pain. BMC women's health, 2022, 05-10, Volume: 22, Issue:1 Topics: Chronic Pain; Contraceptives, Oral, Combined; Endometriosis; Estradiol; Female; Humans; Male; Megestrol; Nandrolone; Norpregnadienes; Pelvic Pain; Quality of Life	2022
Comparison of the effectiveness of Dienogest with medroxyprogesterone acetate in the treatment of pelvic pain and recurrence of endometriosis after laparoscopic surgery. Archives of gynecology and obstetrics, 2023, Volume: 308, Issue:1 Topics: Endometriosis; Female; Humans; Laparoscopy; Medroxyprogesterone Acetate; Nandrolone; Pelvic Pain	2023
The clinical outcome of Dienogest treatment followed by in vitro fertilization and embryo transfer in infertile women with endometriosis. Journal of ovarian research, 2019, Dec-12, Volume: 12, Issue:1 Topics: Adult; Cytokines; Embryo Transfer; Endometriosis; Female; Fertilization in Vitro; Follicular Fluid; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Infertility, Female; Nandrolone; Oxidative Stress; Treatment Outcome	2019
Safety and Effectiveness of Dienogest (Visanne®) for Treatment of Endometriosis: A Large Prospective Cohort Study. Reproductive sciences (Thousand Oaks, Calif.), 2020, Volume: 27, Issue:3 Topics: Adult; Endometriosis; Female; Hormone Antagonists; Humans; Middle Aged; Nandrolone; Pain; Prospective Studies; Treatment Outcome	2020
A randomized, double-blind, placebo-controlled pilot study of the comparative effects of dienogest and the combined oral contraceptive pill in women with endometriosis. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2022, Volume: 156, Issue:1 Topics: Contraceptives, Oral, Combined; Endometriosis; Female; Humans; Nandrolone; Pilot Projects; Quality of Life	2022
Role of suppression of endometriosis with progestins before IVF-ET: a non-inferiority randomized controlled trial. BMC pregnancy and childbirth, 2021, Mar-30, Volume: 21, Issue:1 Topics: Adult; Embryo Transfer; Endometriosis; Female; Humans; Infertility, Female; Leuprolide; Nandrolone; Ovulation Induction; Pregnancy; Pregnancy Outcome; Pregnancy Rate; Progestins; Treatment Outcome	2021
Dienogest vs GnRH agonists as postoperative therapy after laparoscopic eradication of deep infiltrating endometriosis with bowel and parametrial surgery: a randomized controlled trial. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2021, Volume: 37, Issue:10 Topics: Endometriosis; Female; Gonadotropin-Releasing Hormone; Humans; Intestines; Laparoscopy; Leuprolide; Nandrolone; Pelvic Pain; Peritoneum; Postoperative Care; Pregnancy; Recurrence; Reoperation; Secondary Prevention; Treatment Outcome; Triptorelin Pamoate	2021
Dienogest for Treatment of Endometriosis in Chinese Women: A Placebo-Controlled, Randomized, Double-Blind Phase 3 Study. Journal of women's health (2002), 2018, Volume: 27, Issue:2 Topics: Adolescent; Adult; Asian People; Bone Density; China; Double-Blind Method; Endometriosis; Female; Humans; Middle Aged; Nandrolone; Pain Measurement; Pelvic Pain; Progestins; Treatment Outcome; Young Adult	2018
Short-term histopathological effects of dienogest therapy on ovarian endometriomas: in vivo, nonrandomized, controlled trial. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2018, Volume: 34, Issue:5 Topics: Adult; Endometriosis; Endometrium; Female; Humans; Inflammation; Middle Aged; Nandrolone; Ovarian Diseases; Prospective Studies; Treatment Outcome; Young Adult	2018
Comparison of dienogest effects upon 3,3'-diindolylmethane supplementation in models of endometriosis and clinical cases. Reproductive biology, 2018, Volume: 18, Issue:3 Topics: Cell Line; Cell Proliferation; Drug Therapy, Combination; Endometriosis; Endometrium; Female; Humans; Indoles; Nandrolone	2018
Dienogest for Treatment of Endometriosis in Women: A 28-Week, Open-Label, Extension Study. Journal of women's health (2002), 2019, Volume: 28, Issue:2 Topics: Asian People; Bone Density; China; Double-Blind Method; Endometriosis; Female; Hormone Antagonists; Humans; Nandrolone; Pain Measurement; Pelvic Pain; Treatment Outcome	2019
Oral contraceptives in the prevention of endometrioma recurrence: does the different progestins used make a difference? Archives of gynecology and obstetrics, 2013, Volume: 288, Issue:4 Topics: Adolescent; Adult; Combined Modality Therapy; Contraceptives, Oral; Desogestrel; Drug Administration Schedule; Endometriosis; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Laparoscopy; Nandrolone; Norpregnenes; Ovarian Diseases; Secondary Prevention; Treatment Outcome; Young Adult	2013
Dienogest in women with persistent endometriosis-related pelvic pain during norethisterone acetate treatment. European journal of obstetrics, gynecology, and reproductive biology, 2014, Volume: 183 Topics: Adult; Contraceptives, Oral; Endometriosis; Female; Follow-Up Studies; Humans; Nandrolone; Norethindrone; Norethindrone Acetate; Pain Measurement; Patient Satisfaction; Pelvic Pain; Pilot Projects; Prospective Studies; Quality of Life; Rectal Diseases; Treatment Outcome; Vaginal Diseases	2014
Gonadotrophin-releasing hormone analogue or dienogest plus estradiol valerate to prevent pain recurrence after laparoscopic surgery for endometriosis: a multi-center randomized trial. Acta obstetricia et gynecologica Scandinavica, 2015, Volume: 94, Issue:6 Topics: Adolescent; Adult; Drug Combinations; Endometriosis; Estradiol; Female; Gonadotropin-Releasing Hormone; Humans; Italy; Laparoscopy; Middle Aged; Nandrolone; Pain Management; Pain Measurement; Pelvic Pain; Prospective Studies; Quality of Life; Recurrence; Surveys and Questionnaires	2015
Dienogest compared with gonadotropin-releasing hormone agonist after conservative surgery for endometriosis. The journal of obstetrics and gynaecology research, 2016, Volume: 42, Issue:9 Topics: Adult; Conservative Treatment; Endometriosis; Female; Gonadotropin-Releasing Hormone; Goserelin; Hormone Antagonists; Humans; Nandrolone; Pain; Postoperative Care; Prospective Studies; Recurrence; Secondary Prevention	2016
Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis--a randomized, double-blind, multicenter, controlled trial. Fertility and sterility, 2009, Volume: 91, Issue:3 Topics: Abdominal Pain; Administration, Intranasal; Administration, Oral; Bone Density; Buserelin; Double-Blind Method; Dyspareunia; Endometriosis; Female; Humans; Japan; Low Back Pain; Nandrolone; Pain; Pain Measurement; Treatment Outcome	2009
Dienogest and the breast. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2009, Volume: 25, Issue:7 Topics: Adult; Breast; Endometriosis; Female; Fibrocystic Breast Disease; Hormone Antagonists; Humans; Nandrolone; Pilot Projects; Ultrasonography, Mammary; Young Adult	2009
A dose-ranging study to determine the efficacy and safety of 1, 2, and 4mg of dienogest daily for endometriosis. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2010, Volume: 108, Issue:1 Topics: Adult; Dose-Response Relationship, Drug; Endometriosis; Female; Fertility; Hormone Antagonists; Humans; Laparoscopy; Nandrolone; Statistics, Nonparametric; Treatment Outcome; Young Adult	2010
Effect and safety of high-dose dienogest (20 mg/day) in the treatment of women with endometriosis. Archives of gynecology and obstetrics, 2010, Volume: 282, Issue:5 Topics: Adolescent; Adult; Antithrombin III; Cholesterol; Dose-Response Relationship, Drug; Endometriosis; Female; Hormone Antagonists; Humans; Middle Aged; Nandrolone; Peptide Fragments; Pilot Projects; Protein C; Prothrombin; Surveys and Questionnaires; Young Adult	2010
Long-term use of dienogest for the treatment of endometriosis. The journal of obstetrics and gynaecology research, 2009, Volume: 35, Issue:6 Topics: Adult; Bone Density; Endometriosis; Female; Hormone Antagonists; Humans; Longitudinal Studies; Middle Aged; Nandrolone; Prospective Studies; Young Adult	2009
Dienogest is as effective as leuprolide acetate in treating the painful symptoms of endometriosis: a 24-week, randomized, multicentre, open-label trial. Human reproduction (Oxford, England), 2010, Volume: 25, Issue:3 Topics: Adult; Bone Density; Endometriosis; Female; Humans; Leuprolide; Nandrolone; Pelvic Pain; Progestins; Quality of Life	2010
Dienogest in the treatment of endometriosis-associated pelvic pain: a 12-week, randomized, double-blind, placebo-controlled study. European journal of obstetrics, gynecology, and reproductive biology, 2010, Volume: 151, Issue:2 Topics: Adolescent; Adult; Double-Blind Method; Endometriosis; Europe; Female; Humans; Middle Aged; Nandrolone; Pain Measurement; Pelvic Pain; Progesterone Congeners; Quality of Life; Surveys and Questionnaires; Young Adult	2010
Maintenance therapy with dienogest following gonadotropin-releasing hormone agonist treatment for endometriosis-associated pelvic pain. European journal of obstetrics, gynecology, and reproductive biology, 2011, Volume: 157, Issue:2 Topics: Adult; Buserelin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Endometriosis; Female; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Middle Aged; Nandrolone; Pelvic Pain; Prospective Studies; Time Factors; Treatment Outcome; Uterine Hemorrhage	2011
Reduced pelvic pain in women with endometriosis: efficacy of long-term dienogest treatment. Archives of gynecology and obstetrics, 2012, Volume: 285, Issue:1 Topics: Adolescent; Adult; Drug Administration Schedule; Endometriosis; Female; Follow-Up Studies; Germany; Hormone Antagonists; Humans; Italy; Middle Aged; Nandrolone; Pelvic Pain; Ukraine; Young Adult	2012
Detailed analysis of a randomized, multicenter, comparative trial of dienogest versus leuprolide acetate in endometriosis. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2012, Volume: 117, Issue:3 Topics: Adolescent; Adult; Antineoplastic Agents, Hormonal; Dysmenorrhea; Endometriosis; Estrogens; Female; Humans; Leuprolide; Middle Aged; Nandrolone; Pelvic Pain; Quality of Life; Severity of Illness Index; Surveys and Questionnaires; Young Adult	2012
[Treatment of endometriosis with dienogest: preliminary report]. Ginekologia polska, 2001, Volume: 72, Issue:5 Topics: Adult; Antineoplastic Agents, Hormonal; Endometriosis; Female; Humans; Nandrolone; Pelvic Inflammatory Disease; Severity of Illness Index; Treatment Outcome	2001
Dienogest is as effective as triptorelin in the treatment of endometriosis after laparoscopic surgery: results of a prospective, multicenter, randomized study. Fertility and sterility, 2002, Volume: 77, Issue:4 Topics: Adolescent; Adult; Alkaline Phosphatase; Cholesterol; Cholesterol, HDL; Combined Modality Therapy; Endometriosis; Female; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Laparoscopy; Nandrolone; Triptorelin Pamoate	2002
[Steroid receptors in the gestagen treatment of endometriosis]. Therapeutische Umschau. Revue therapeutique, 1990, Volume: 47, Issue:12 Topics: Adult; Endometriosis; Female; Humans; Nandrolone; Progesterone Congeners; Progestins; Receptors, Estrogen; Receptors, Progesterone; Uterine Neoplasms	1990

Other Studies

115 other study(ies) available for nandrolone and Endometrioma

Article	Year
Dienogest-induced major depressive disorder with suicidal ideation: A case report. Medicine, 2021, Oct-08, Volume: 100, Issue:40 Topics: Adult; Depressive Disorder, Major; Endometriosis; Female; Hormone Antagonists; Humans; Nandrolone; Suicidal Ideation	2021
Impact of Long-Term Dienogest Therapy on Quality of Life in Asian Women with Endometriosis: the Prospective Non-Interventional Study ENVISIOeN. Reproductive sciences (Thousand Oaks, Calif.), 2022, Volume: 29, Issue:4 Topics: Adolescent; Adult; Amenorrhea; Endometriosis; Female; Humans; Nandrolone; Pelvic Pain; Prospective Studies; Quality of Life	2022
A prospective study examining the effect of dienogest treatment on endometrioma size and symptoms. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2022, Volume: 38, Issue:5 Topics: Adult; Endometriosis; Female; Humans; Nandrolone; Pelvic Pain; Prospective Studies; Quality of Life; Treatment Outcome	2022
Efficacy of Post-Operative Medication to Prevent Recurrence of Endometrioma: Cyclic Oral Contraceptive (OC) After Gonadotropin-Releasing Hormone (GnRH) Agonist Versus Dienogest. Journal of Korean medical science, 2022, 07-04, Volume: 37, Issue:26 Topics: Contraception; Contraceptives, Oral; Endometriosis; Female; Gonadotropin-Releasing Hormone; Humans; Nandrolone; Retrospective Studies; Secondary Prevention	2022
Cost-effectiveness Analysis of Dienogest Compared with Combined Oral Contraceptives after Surgery for Endometriosis. Journal of minimally invasive gynecology, 2023, Volume: 30, Issue:4 Topics: Contraceptives, Oral, Combined; Cost-Benefit Analysis; Cost-Effectiveness Analysis; Endometriosis; Female; Humans; Nandrolone; Quality-Adjusted Life Years	2023
Is dienogest a convenient treatment option for cesarean scar endometriosis or should it be treated surgically? European journal of obstetrics, gynecology, and reproductive biology, 2023, Volume: 282 Topics: Adult; Cicatrix; Endometriosis; Female; Humans; Nandrolone; Pelvic Pain; Prospective Studies; Treatment Outcome	2023
Quality of life and clinical factors in women with endometriosis, the role of dienogest vs EE/dienogest over time: a single-center study. Archives of gynecology and obstetrics, 2023, Volume: 307, Issue:5 Topics: Dysmenorrhea; Endometriosis; Female; Humans; Nandrolone; Quality of Life; Treatment Outcome	2023
Genome-Wide Gene Expression Profiling Reveals the Direct Effect of Dienogest on Ovarian Endometriotic Stromal Cells. Reproductive sciences (Thousand Oaks, Calif.), 2023, Volume: 30, Issue:8 Topics: Endometriosis; Female; Gene Expression Profiling; Humans; Nandrolone; Progestins; Stromal Cells	2023
Comparison of the efficacy of dienogest and GnRH-a after endometriosis surgery. BMC women's health, 2023, 02-24, Volume: 23, Issue:1 Topics: Endometriosis; Female; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Nandrolone	2023
Endometriosis features and dienogest tolerability in women with depression: a case-control study. The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception, 2023, Volume: 28, Issue:3 Topics: Case-Control Studies; Depression; Dysmenorrhea; Endometriosis; Female; Humans; Nandrolone; Pelvic Pain	2023
Dienogest alone or dienogest combined with estrogens in the treatment of ovarian endometriomas, that is the question. A retrospective cohort study. Archives of gynecology and obstetrics, 2023, Volume: 308, Issue:4 Topics: Dysmenorrhea; Dysuria; Endometriosis; Estradiol; Estrogens; Female; Humans; Nandrolone; Retrospective Studies	2023
Severe hemoperitoneum due to endometriosis in a non-pregnant woman under dienogest therapy: a case report. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2020, Volume: 36, Issue:3 Topics: Adnexal Diseases; Adult; Endometriosis; Female; Hemoperitoneum; Hemostasis, Surgical; Hormone Antagonists; Humans; Laparoscopy; Ligaments; Nandrolone; Severity of Illness Index	2020
Significant risk factors for malignant transformation of ovarian endometrioma during dienogest treatment: a case report and retrospective study. Journal of medical case reports, 2019, Oct-22, Volume: 13, Issue:1 Topics: Adenocarcinoma, Clear Cell; Adult; Age Factors; Cell Transformation, Neoplastic; Contraceptives, Oral, Hormonal; Endometriosis; Female; Humans; Middle Aged; Nandrolone; Ovarian Diseases; Ovarian Neoplasms; Parity; Retrospective Studies; Risk Factors	2019
Dienogest regulates apoptosis, proliferation, and invasiveness of endometriotic cyst stromal cells via endoplasmic reticulum stress induction. Molecular human reproduction, 2020, 01-01, Volume: 26, Issue:1 Topics: Activating Transcription Factor 4; Adult; Apoptosis; Cell Movement; Cell Proliferation; Cysts; eIF-2 Kinase; Endometriosis; Endometrium; Endoplasmic Reticulum; Endoplasmic Reticulum Stress; Endoribonucleases; Female; Gene Expression Regulation; Hormone Antagonists; Humans; MAP Kinase Kinase Kinase 5; MAP Kinase Signaling System; Nandrolone; Progesterone; Protein Serine-Threonine Kinases; RNA, Small Interfering; Stromal Cells; TNF Receptor-Associated Factor 2; Transcription Factor CHOP	2020
Efficacy of dienogest treatment of clinical symptoms of rectovaginal endometriosis. Ceska gynekologie, 2019,Summer, Volume: 84, Issue:5 Topics: Cohort Studies; Endometriosis; Female; Hormone Antagonists; Humans; Nandrolone; Pain Measurement; Pelvic Pain; Prospective Studies; Quality of Life; Rectum; Treatment Outcome; Vagina	2019
Uterine adenomyosis is an oligoclonal disorder associated with KRAS mutations. Nature communications, 2019, 12-19, Volume: 10, Issue:1 Topics: Adenomyosis; Adult; Cell Proliferation; DNA Mutational Analysis; Endometriosis; Endometrium; Female; High-Throughput Nucleotide Sequencing; Humans; Hysterectomy; Middle Aged; Mutation; Myometrium; Nandrolone; Proto-Oncogene Proteins p21(ras); Receptors, Progesterone; Treatment Outcome; Young Adult	2019
Effect of Dienogest therapy on the size of the endometrioma. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2020, Volume: 36, Issue:8 Topics: Adult; Dysmenorrhea; Dyspareunia; Endometriosis; Endometrium; Female; Humans; Italy; Middle Aged; Nandrolone; Organ Size; Pelvic Pain; Peritoneal Diseases; Prospective Studies; Severity of Illness Index; Treatment Outcome; Young Adult	2020
Safety of Dienogest and Other Hormonal Treatments for Endometriosis in Real-World Clinical Practice (VIPOS): A Large Noninterventional Study. Advances in therapy, 2020, Volume: 37, Issue:5 Topics: Adult; Endometriosis; Europe; Female; Germany; Hormone Antagonists; Humans; Nandrolone; Pelvic Pain; Prospective Studies; Research Design; Women's Health	2020
Risk of depression and anemia in users of hormonal endometriosis treatments: Results from the VIPOS study. European journal of obstetrics, gynecology, and reproductive biology, 2020, Volume: 251 Topics: Anemia; Depression; Endometriosis; Europe; Female; Humans; Nandrolone; Prospective Studies	2020
Comparison of effect of preoperative dienogest and gonadotropin-releasing hormone agonist administration on laparoscopic cystectomy for ovarian endometriomas. Archives of gynecology and obstetrics, 2020, Volume: 302, Issue:4 Topics: Adolescent; Adult; Contraceptives, Oral, Hormonal; Cystectomy; Endometriosis; Female; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Laparoscopy; Middle Aged; Nandrolone; Preoperative Period; Prospective Studies; Young Adult	2020
Risk factors for non-response and discontinuation of Dienogest in endometriosis patients: A cohort study. Acta obstetricia et gynecologica Scandinavica, 2021, Volume: 100, Issue:1 Topics: Adult; Endometriosis; Female; Hormone Antagonists; Humans; Nandrolone; Retrospective Studies; Risk Factors	2021
Pretreatment with dienogest in women with endometriosis undergoing IVF after a previous failed cycle. Reproductive biomedicine online, 2020, Volume: 41, Issue:5 Topics: Adult; Birth Rate; Embryo Transfer; Endometriosis; Female; Fertilization in Vitro; Hormone Antagonists; Humans; Nandrolone; Oocyte Retrieval; Ovulation Induction; Pregnancy; Pregnancy Rate; Retrospective Studies	2020
New treatment strategy for endometriosis using progestin-primed ovarian stimulation with dienogest: A prospective cohort study, comparison of dienogest versus dydrogesterone. Reproductive biology, 2021, Volume: 21, Issue:1 Topics: Adult; Cohort Studies; Dydrogesterone; Endometriosis; Female; Humans; Nandrolone; Ovary; Pregnancy; Progestins; Prospective Studies	2021
Identification of biomarkers for drug-resistant endometriosis using clinical proteomics. Human cell, 2021, Volume: 34, Issue:2 Topics: Antimicrobial Cationic Peptides; Blood Proteins; Carcinogenesis; Cell Line; Drug Resistance; Endometriosis; Female; Humans; Insulin-Like Growth Factor Binding Protein 1; Nandrolone; Proteomics	2021
The Long-Term Effect of Dienogest on Bone Mineral Density After Surgical Treatment of Endometrioma. Reproductive sciences (Thousand Oaks, Calif.), 2021, Volume: 28, Issue:5 Topics: Adult; Bone Density; Endometriosis; Female; Humans; Nandrolone; Postoperative Complications; Retrospective Studies	2021
Evaluating the safety of dienogest in women with adenomyosis: A retrospective analysis. The journal of obstetrics and gynaecology research, 2021, Volume: 47, Issue:4 Topics: Adenomyosis; Endometriosis; Female; Humans; Nandrolone; Retrospective Studies	2021
Dienogest reduces endometrioma volume and endometriosis-related pain symptoms. Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology, 2021, Volume: 41, Issue:8 Topics: Adult; Contraceptives, Oral, Hormonal; Endometriosis; Endometrium; Female; Humans; Menstruation Disturbances; Nandrolone; Organ Size; Pain Measurement; Pelvic Pain; Prospective Studies; Treatment Outcome; Uterine Diseases	2021
Successful treatment of peritoneal inclusion cysts with dienogest: two case reports. Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology, 2022, Volume: 42, Issue:3 Topics: Cysts; Endometriosis; Humans; Nandrolone; Peritoneal Diseases	2022
Cost-effectiveness Analysis of Dienogest Compared With Gonadotropin-Releasing Hormone Agonist After Conservative Surgery for Endometriosis in China. Clinical therapeutics, 2021, Volume: 43, Issue:8 Topics: China; Cost-Benefit Analysis; Endometriosis; Female; Gonadotropin-Releasing Hormone; Humans; Nandrolone	2021
Effects of long-term postoperative dienogest use for treatment of endometriosis on bone mineral density. European journal of obstetrics, gynecology, and reproductive biology, 2017, Volume: 212 Topics: Absorptiometry, Photon; Adult; Bone Density; Contraceptives, Oral; Endometriosis; Female; Femur Neck; Humans; Lumbar Vertebrae; Nandrolone; Prospective Studies; Secondary Prevention	2017
The association between progestins, nuclear receptors expression and inflammation in endometrial stromal cells from women with endometriosis. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2017, Volume: 33, Issue:9 Topics: Adult; Cytokines; Endometriosis; Endometrium; Female; Humans; Inflammation; Medroxyprogesterone Acetate; Nandrolone; Norethindrone; Norethindrone Acetate; Progestins; Receptors, Androgen; Receptors, Glucocorticoid; Receptors, Progesterone; Receptors, Steroid; Stromal Cells; Tumor Necrosis Factor-alpha	2017
Efficacy comparison of oral rosuvastatin versus oral progesterone and bevacizumab on regression of surgically endometriotic implants in rats. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2017, Volume: 33, Issue:12 Topics: Angiogenesis Inhibitors; Animals; Bevacizumab; Drug Evaluation, Preclinical; Endometriosis; Female; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Nandrolone; Rats, Wistar; Rosuvastatin Calcium	2017
Dienogest inhibits C-C motif chemokine ligand 20 expression in human endometriotic epithelial cells. European journal of obstetrics, gynecology, and reproductive biology, 2017, Volume: 214 Topics: Cell Line; Chemokine CCL20; Endometriosis; Epithelial Cells; Female; Humans; Interleukin-1beta; Mifepristone; Nandrolone; Receptors, Progesterone	2017
Clinical dynamics of Dienogest for the treatment of endometriosis: from bench to bedside. Expert opinion on drug metabolism & toxicology, 2017, Volume: 13, Issue:6 Topics: Disease Progression; Drug Design; Endometriosis; Female; Hormone Antagonists; Humans; Nandrolone	2017
Efficacy of dienogest in improving pain in women with endometriosis: a 12-month single-center experience. Archives of gynecology and obstetrics, 2017, Volume: 296, Issue:3 Topics: Adolescent; Adult; Cohort Studies; Dyspareunia; Endometriosis; Female; Hormone Antagonists; Humans; Middle Aged; Nandrolone; Pain Measurement; Pelvic Pain; Treatment Outcome	2017
Effect of dienogest on pain and ovarian endometrioma occurrence after laparoscopic resection of uterosacral ligaments with deep infiltrating endometriosis. European journal of obstetrics, gynecology, and reproductive biology, 2017, Volume: 216 Topics: Endometriosis; Female; Hormone Antagonists; Humans; Laparoscopy; Nandrolone; Ovarian Diseases; Pain; Peritoneal Diseases; Recurrence; Retrospective Studies; Secondary Prevention; Treatment Outcome	2017
Efficacy and Safety of Long-Term Use of Dienogest in Women With Ovarian Endometrioma. Reproductive sciences (Thousand Oaks, Calif.), 2018, Volume: 25, Issue:3 Topics: Adult; Endometriosis; Female; Hormone Antagonists; Humans; Middle Aged; Nandrolone; Ovarian Diseases; Pain Measurement; Recurrence; Retrospective Studies; Treatment Outcome; Ultrasonography; Young Adult	2018
Dienogest treatment after ovarian endometrioma removal in infertile women prior to IVF. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2017, Volume: 33, Issue:sup1 Topics: Adult; Endometriosis; Female; Fertilization in Vitro; Hormone Antagonists; Humans; Infertility, Female; Nandrolone; Ovarian Diseases; Ovulation Induction; Pregnancy; Pregnancy Rate; Prospective Studies; Treatment Outcome	2017
Treatment of premenstrual mood changes in a patient with schizophrenia using dienogest: A case report. The journal of obstetrics and gynaecology research, 2018, Volume: 44, Issue:4 Topics: Adult; Endometriosis; Female; Hormone Antagonists; Humans; Nandrolone; Premenstrual Syndrome; Schizophrenia	2018
Efficacy, safety and recurrence of new progestins and selective progesterone receptor modulator for the treatment of endometriosis: a comparison study in mice. Reproductive biology and endocrinology : RB&E, 2018, Apr-03, Volume: 16, Issue:1 Topics: Animals; Apoptosis; Atrophy; Cell Proliferation; Dydrogesterone; Endometrial Hyperplasia; Endometriosis; Endometrium; Female; Mice; Mice, Inbred C57BL; Nandrolone; Norpregnadienes; Progestins; Receptors, Progesterone; Recurrence	2018
Complete remission of cerebral endometriosis with dienogest: a case report. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2018, Volume: 34, Issue:10 Topics: Adult; Brain; Brain Diseases; Endometriosis; Female; Hormone Antagonists; Humans; Magnetic Resonance Imaging; Nandrolone; Treatment Outcome	2018
Symptom-alleviating effect and adverse effect of dienogest in Korean women with endometriosis. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2018, Volume: 34, Issue:11 Topics: Adult; Alopecia; Cross-Sectional Studies; Depression; Endometriosis; Female; Humans; Menstruation; Menstruation Disturbances; Middle Aged; Nandrolone; Pelvic Pain; Premenopause; Quality of Life; Recurrence; Republic of Korea; Surveys and Questionnaires; Time Factors; Weight Gain	2018
When Solving Dyspareunia Is Not Enough to Restore Sexual Function in Women With Deep Infiltrating Endometriosis Treated With Dienogest. Journal of sex & marital therapy, 2019, Volume: 45, Issue:1 Topics: Adult; Brazil; Dyspareunia; Endometriosis; Female; Hormone Antagonists; Humans; Middle Aged; Nandrolone; Pelvic Pain; Prospective Studies; Quality of Life; Sexual Dysfunction, Physiological; Treatment Outcome; Young Adult	2019
Effectiveness of Dienogest for Treatment of Recurrent Endometriosis: Multicenter Data. Reproductive sciences (Thousand Oaks, Calif.), 2018, Volume: 25, Issue:10 Topics: Adult; Amenorrhea; CA-125 Antigen; Endometriosis; Female; Hormone Antagonists; Humans; Multicenter Studies as Topic; Nandrolone; Pain; Pain Measurement; Recurrence; Retrospective Studies; Treatment Outcome	2018
Comparison of the efficacy of diegnogest and levonorgestrel-releasing intrauterine system after laparoscopic surgery for endometriosis. The journal of obstetrics and gynaecology research, 2018, Volume: 44, Issue:9 Topics: Adult; Contraceptive Agents, Female; Endometriosis; Female; Humans; Intrauterine Devices, Medicated; Laparoscopy; Levonorgestrel; Middle Aged; Nandrolone; Outcome Assessment, Health Care; Pain, Postoperative; Pelvic Pain; Young Adult	2018
Dienogest therapy during the early stages of recurrence of endometrioma might be an alternative therapeutic option to avoid repeat surgeries. The journal of obstetrics and gynaecology research, 2018, Volume: 44, Issue:10 Topics: Adult; Endometriosis; Female; Hormone Antagonists; Humans; Nandrolone; Recurrence; Reoperation; Young Adult	2018
Long-term treatment of endometriosis with dienogest: retrospective analysis of efficacy and safety in clinical practice. Archives of gynecology and obstetrics, 2018, Volume: 298, Issue:4 Topics: Adult; Endometriosis; Female; Humans; Middle Aged; Nandrolone; Pelvic Pain; Retrospective Studies	2018
A case of unique endoscopic findings of intestinal endometriosis exposed to the mucosa: aggregation of papillary protruded bulges from the submucosal elevation of the rectum. Clinical journal of gastroenterology, 2019, Volume: 12, Issue:2 Topics: Adult; Colonoscopy; Endometriosis; Female; Hormone Antagonists; Humans; Intestinal Mucosa; Nandrolone; Rectal Diseases	2019
Pain-related behavior and brain activation in cynomolgus macaques with naturally occurring endometriosis. Human reproduction (Oxford, England), 2019, 03-01, Volume: 34, Issue:3 Topics: Acetaminophen; Analgesics; Animals; Behavior, Animal; Brain; Central Nervous System; Endometriosis; Female; Macaca fascicularis; Magnetic Resonance Imaging; Meloxicam; Morphine; Nandrolone; Pain	2019
Comparison of long-term use of combined oral contraceptive after gonadotropin-releasing hormone agonist plus add-back therapy versus dienogest to prevent recurrence of ovarian endometrioma after surgery. European journal of obstetrics, gynecology, and reproductive biology, 2019, Volume: 236 Topics: Adult; Contraceptives, Oral, Combined; Endometriosis; Female; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Nandrolone; Ovarian Diseases; Prospective Studies; Secondary Prevention; Young Adult	2019
Umbilical endometriosis (Villar's nodule). American journal of obstetrics and gynecology, 2019, Volume: 221, Issue:6 Topics: Adult; Endometriosis; Female; Hormone Antagonists; Humans; Nandrolone; Umbilicus	2019
Effectiveness of dienogest in improving quality of life in Asian women with endometriosis (ENVISIOeN): interim results from a prospective cohort study under real-life clinical practice. BMC women's health, 2019, 05-16, Volume: 19, Issue:1 Topics: Adult; Asian People; Cohort Studies; Endometriosis; Female; Hormone Antagonists; Humans; Middle Aged; Nandrolone; Pelvic Pain; Prospective Studies; Quality of Life; Severity of Illness Index; Treatment Outcome	2019
Dienogest or Norethindrone acetate for the treatment of ovarian endometriomas: Can we avoid surgery? European journal of obstetrics, gynecology, and reproductive biology, 2019, Volume: 238 Topics: Adult; Contraceptives, Oral, Hormonal; Endometriosis; Female; Humans; Nandrolone; Norethindrone; Ovarian Diseases; Retrospective Studies	2019
Is dienogest the best medical treatment for ovarian endometriomas? Results of a multicentric case control study. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2020, Volume: 36, Issue:1 Topics: Adult; Case-Control Studies; Contraceptives, Oral, Combined; Endometriosis; Ethinyl Estradiol; Female; Hormone Antagonists; Humans; Nandrolone; Ovarian Diseases; Pelvic Pain; Treatment Outcome; Young Adult	2020
Clinical aspects and management of inguinal endometriosis: A case series of 20 patients. The journal of obstetrics and gynaecology research, 2019, Volume: 45, Issue:10 Topics: Adult; Endometriosis; Female; Gynecologic Surgical Procedures; Hormone Antagonists; Humans; Inguinal Canal; Magnetic Resonance Imaging; Middle Aged; Nandrolone; Recurrence; Retrospective Studies	2019
Postoperative administration of dienogest plus estradiol valerate versus levonorgestrel-releasing intrauterine device for prevention of pain relapse and disease recurrence in endometriosis patients. The journal of obstetrics and gynaecology research, 2013, Volume: 39, Issue:5 Topics: Adult; Combined Modality Therapy; Contraceptive Agents, Female; Drug Combinations; Endometriosis; Estradiol; Estrogens; Female; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Nandrolone; Patient Satisfaction; Pelvic Pain; Postoperative Care; Receptors, Progesterone; Retrospective Studies; Secondary Prevention	2013
[Endometriosis, an underestimated disease: reducing pelvic pain effectively and lastingly]. Revue medicale suisse, 2013, Jun-26, Volume: 9, Issue:392 Topics: Analgesics; Contraceptives, Oral; Endometriosis; Female; Humans; Nandrolone; Pelvic Pain; Treatment Outcome	2013
Effect of a dienogest for an experimental three-dimensional endometrial culture model for endometriosis. Medical molecular morphology, 2014, Volume: 47, Issue:4 Topics: Adult; Apoptosis; Cell Culture Techniques; Cell Proliferation; Cells, Cultured; Endometriosis; Endometrium; Epithelial Cells; Female; Hormone Antagonists; Humans; Middle Aged; Models, Biological; Nandrolone; Tissue Culture Techniques	2014
Surgery versus pharmacological treatment for endometriosis. Women's health (London, England), 2014, Volume: 10, Issue:2 Topics: Anti-Inflammatory Agents, Non-Steroidal; Contraceptives, Oral, Combined; Endometriosis; Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Gynecologic Surgical Procedures; Humans; Infertility, Female; Intrauterine Devices, Medicated; Laparoscopy; Levonorgestrel; Nandrolone; Pelvic Pain; Progestins	2014
Dienogest improves human leucocyte antigen-DR underexpression and reduces tumour necrosis factor-α production in peritoneal fluid cells from women with endometriosis. European journal of obstetrics, gynecology, and reproductive biology, 2014, Volume: 177 Topics: Adult; Ascitic Fluid; Cells, Cultured; Endometriosis; Female; HLA-DR Antigens; Hormone Antagonists; Humans; Macrophages; Nandrolone; Peritoneal Diseases; Tumor Necrosis Factor-alpha	2014
Dienogest reduces proliferation, aromatase expression and angiogenesis, and increases apoptosis in human endometriosis. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2014, Volume: 30, Issue:9 Topics: Antineoplastic Agents, Hormonal; Apoptosis; Aromatase; Case-Control Studies; Cell Proliferation; Endometriosis; Female; Humans; In Situ Nick-End Labeling; Ki-67 Antigen; Nandrolone; Neovascularization, Pathologic; von Willebrand Factor	2014
Prediction of the therapeutic effect of dienogest in ovarian endometrial cysts using the apparent diffusion coefficient. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2014, Volume: 30, Issue:8 Topics: Adult; Antineoplastic Agents, Hormonal; Biomarkers, Pharmacological; Diffusion; Diffusion Magnetic Resonance Imaging; Endometriosis; Female; Humans; Middle Aged; Nandrolone; Ovarian Cysts; Predictive Value of Tests; Prognosis; Retrospective Studies	2014
Relief of uterine bleeding by cyclic administration of dienogest for endometriosis. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2014, Volume: 30, Issue:11 Topics: Adult; Drug Administration Schedule; Endometriosis; Female; Hormone Antagonists; Humans; Nandrolone; Ovarian Diseases; Treatment Outcome; Uterine Hemorrhage; Young Adult	2014
Endometriosis associated with relapsing ascites and pleural effusions. Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology, 2015, Volume: 35, Issue:4 Topics: Adult; Ascites; Endometriosis; Female; Hormone Antagonists; Humans; Leuprolide; Nandrolone; Ovarian Cysts; Paracentesis; Peritoneal Cavity; Pleura; Pleural Effusion; Treatment Outcome	2015
Urinary incontinence and bladder endometriosis: conservative management. International urogynecology journal, 2015, Volume: 26, Issue:1 Topics: Adult; Antineoplastic Agents, Hormonal; Endometriosis; Female; Humans; Nandrolone; Urinary Bladder Diseases; Urinary Incontinence	2015
Decorin induced by progesterone plays a crucial role in suppressing endometriosis. The Journal of endocrinology, 2014, Volume: 223, Issue:2 Topics: Adult; Cell Cycle; Cells, Cultured; Cross-Sectional Studies; Decorin; Endometriosis; Female; Humans; Middle Aged; Nandrolone; Ovarian Diseases; Progesterone; Retrospective Studies; Transcriptional Activation; Young Adult	2014
Pelvic pain and quality of life of women with endometriosis during quadriphasic estradiol valerate/dienogest oral contraceptive: a patient-preference prospective 24-week pilot study. Reproductive sciences (Thousand Oaks, Calif.), 2015, Volume: 22, Issue:5 Topics: Adult; Contraceptives, Oral, Hormonal; Drug Combinations; Dysmenorrhea; Endometriosis; Estradiol; Female; Hospitals, University; Humans; Italy; Nandrolone; Pain Measurement; Patient Preference; Pelvic Pain; Pilot Projects; Prospective Studies; Quality of Life; Surveys and Questionnaires; Time Factors; Treatment Outcome	2015
Dienogest, a synthetic progestin, down-regulates expression of CYP19A1 and inflammatory and neuroangiogenesis factors through progesterone receptor isoforms A and B in endometriotic cells. The Journal of steroid biochemistry and molecular biology, 2015, Volume: 147 Topics: Aromatase; Cell Line; Cytokines; Down-Regulation; Endometriosis; Female; Humans; Intramolecular Oxidoreductases; Nandrolone; Nerve Growth Factor; Progesterone Congeners; Prostaglandin-E Synthases; Receptors, Progesterone; RNA, Messenger; Vascular Endothelial Growth Factor A	2015
Dienogest reduces HSD17β1 expression and activity in endometriosis. The Journal of endocrinology, 2015, Volume: 225, Issue:2 Topics: Adult; Aromatase; Cells, Cultured; Endometriosis; Endometrium; Estradiol Dehydrogenases; Female; Gene Expression Regulation, Enzymologic; Humans; Nandrolone; Young Adult	2015
Dienogest. A possible conservative approach in bladder endometriosis. Results of a pilot study. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2015, Volume: 31, Issue:5 Topics: Adult; Cohort Studies; Dysuria; Endometriosis; Female; Hematuria; Hormone Antagonists; Humans; Nandrolone; Pilot Projects; Quality of Life; Treatment Outcome; Ultrasonography; Urinary Bladder Diseases	2015
Exploratory study of pre-surgical medications with dienogest or leuprorelin in laparoscopic cystectomy of endometrial cysts. The journal of obstetrics and gynaecology research, 2015, Volume: 41, Issue:8 Topics: Adult; Anti-Mullerian Hormone; Endometriosis; Female; Humans; Laparoscopy; Leuprolide; Nandrolone; Ovarian Cysts; Ovary; Visual Analog Scale	2015
Comparison of dienogest versus triptorelin acetate in premenopausal women with adenomyosis: a prospective clinical trial. Archives of gynecology and obstetrics, 2015, Volume: 292, Issue:6 Topics: Adenomyosis; Administration, Oral; Adult; Endometriosis; Female; Humans; Injections, Subcutaneous; Menorrhagia; Middle Aged; Nandrolone; Pelvic Pain; Premenopause; Prospective Studies; Treatment Outcome; Triptorelin Pamoate	2015
Dienogest enhances autophagy induction in endometriotic cells by impairing activation of AKT, ERK1/2, and mTOR. Fertility and sterility, 2015, Volume: 104, Issue:3 Topics: Apoptosis; Autophagy; Cells, Cultured; Endometriosis; Enzyme Activation; Female; Humans; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Nandrolone; Ovarian Cysts; Phosphorylation; Progesterone; Proto-Oncogene Proteins c-akt; Signal Transduction; Stromal Cells; TOR Serine-Threonine Kinases	2015
Quality of life and sexual function of women affected by endometriosis-associated pelvic pain when treated with dienogest. Journal of endocrinological investigation, 2015, Volume: 38, Issue:11 Topics: Adolescent; Adult; Endometriosis; Female; Follow-Up Studies; Hormone Antagonists; Humans; Nandrolone; Orgasm; Pelvic Pain; Quality of Life; Sexual Behavior; Treatment Outcome; Young Adult	2015
Use of dienogest over 53 weeks for the treatment of endometriosis. The journal of obstetrics and gynaecology research, 2015, Volume: 41, Issue:12 Topics: Adult; CA-125 Antigen; Endometriosis; Estradiol; Female; Humans; Membrane Proteins; Middle Aged; Nandrolone	2015
Norethindrone acetate or dienogest for the treatment of symptomatic endometriosis: a before and after study. Fertility and sterility, 2016, Volume: 105, Issue:3 Topics: Adult; Cost-Benefit Analysis; Drug Costs; Drug Substitution; Endometriosis; Female; Humans; Nandrolone; Norethindrone; Norethindrone Acetate; Patient Satisfaction; Progestins; Quality of Life; Treatment Outcome	2016
Postoperative administration of dienogest for suppressing recurrence of disease and relieving pain in subjects with ovarian endometriomas. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2016, Volume: 32, Issue:8 Topics: Adult; Disease-Free Survival; Endometriosis; Female; Follow-Up Studies; Hormone Antagonists; Humans; Japan; Laparoscopy; Nandrolone; Outcome Assessment, Health Care; Ovarian Diseases; Pain Measurement; Pelvic Pain; Recurrence; Retrospective Studies	2016
Comparative, open-label prospective study on the quality of life and sexual function of women affected by endometriosis-associated pelvic pain on 2 mg dienogest/30 µg ethinyl estradiol continuous or 21/7 regimen oral contraceptive. Journal of endocrinological investigation, 2016, Volume: 39, Issue:8 Topics: Adolescent; Adult; Case-Control Studies; Contraceptives, Oral, Combined; Endometriosis; Estrogens; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; Nandrolone; Pain Measurement; Pelvic Pain; Prognosis; Prospective Studies; Quality of Life; Sexual Behavior; Young Adult	2016
Primary umbilical endometriosis successfully treated with dienogest. Hormone molecular biology and clinical investigation, 2017, Feb-01, Volume: 29, Issue:2 Topics: Adult; Endometriosis; Female; Hormone Antagonists; Humans; Nandrolone; Umbilicus	2017
Dienogest mediates midkine suppression in endometriosis. Human reproduction (Oxford, England), 2016, Volume: 31, Issue:9 Topics: Adult; Ascitic Fluid; Cells, Cultured; Cytokines; Down-Regulation; Drug Discovery; Endometriosis; Endometrium; Female; Hormone Antagonists; Humans; Midkine; Nandrolone; Prospective Studies; Stromal Cells	2016
Progestin suppressed inflammation and cell viability of tumor necrosis factor-α-stimulated endometriotic stromal cells. American journal of reproductive immunology (New York, N.Y. : 1989), 2016, Volume: 76, Issue:4 Topics: Cell Proliferation; Cell Survival; Cells, Cultured; Cellular Microenvironment; Cytokines; Endometriosis; Endometrium; Estrogens; Female; Humans; Immunosuppression Therapy; Inflammation; Medroxyprogesterone Acetate; Nandrolone; Norethindrone; Norethindrone Acetate; Progestins; Stromal Cells; Tumor Necrosis Factor-alpha	2016
Gonadotropin-releasing hormone agonist with add-back treatment is as effective and tolerable as dienogest in preventing pain recurrence after laparoscopic surgery for endometriosis. Archives of gynecology and obstetrics, 2016, Volume: 294, Issue:6 Topics: Adult; Endometriosis; Estradiol; Female; Gonadotropin-Releasing Hormone; Humans; Laparoscopy; Nandrolone; Pelvic Pain; Recurrence	2016
Dienogest 2 mg Daily in the Treatment of Adolescents with Clinically Suspected Endometriosis: The VISanne Study to Assess Safety in ADOlescents. Journal of pediatric and adolescent gynecology, 2017, Volume: 30, Issue:5 Topics: Absorptiometry, Photon; Adolescent; Bone Density; Child; Endometriosis; Europe; Female; Hormone Antagonists; Humans; Lumbar Vertebrae; Nandrolone; Pain Measurement; Pelvic Pain	2017
Dienogest and deep infiltrating endometriosis: The remission of symptoms is not related to endometriosis nodule remission. European journal of obstetrics, gynecology, and reproductive biology, 2017, Volume: 211 Topics: Adult; Constipation; Endometriosis; Female; Hormone Antagonists; Humans; Intestinal Diseases; Nandrolone; Pain Measurement; Pelvic Pain; Prospective Studies; Quality of Life; Treatment Outcome	2017
Effect of dienogest administration on angiogenesis and hemodynamics in a rat endometrial autograft model. Human reproduction (Oxford, England), 2010, Volume: 25, Issue:11 Topics: Animals; Endometriosis; Endometrium; Female; Hemodynamics; Nandrolone; Neovascularization, Physiologic; Rats; Rats, Wistar	2010
Beneficial effects of dienogest on uterine myoma volume: a retrospective controlled study comparing with gonadotropin-releasing hormone agonist. Archives of gynecology and obstetrics, 2011, Volume: 284, Issue:3 Topics: Adult; Antineoplastic Agents, Hormonal; Case-Control Studies; Endometriosis; Female; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Leiomyoma; Leuprolide; Middle Aged; Nandrolone; Premenopause; Retrospective Studies; Tumor Burden; Uterine Neoplasms	2011
Dienogest, a new conservative strategy for extragenital endometriosis: a pilot study. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2011, Volume: 27, Issue:9 Topics: Adult; Antineoplastic Agents, Hormonal; Endometriosis; Female; Humans; Middle Aged; Nandrolone; Pilot Projects; Rectal Diseases; Retrospective Studies; Sigmoid Diseases; Urinary Bladder Diseases	2011
Novel [corrected] medical management of primary bladder endometriosis with dienogest: a case report. Clinical and experimental obstetrics & gynecology, 2011, Volume: 38, Issue:2 Topics: Adult; Endometriosis; Female; Hormone Antagonists; Humans; Nandrolone; Pregnancy; Urinary Bladder; Urinary Bladder Diseases	2011
Effects of dienogest on surgically induced endometriosis in rats after repeated oral administration. Gynecologic and obstetric investigation, 2011, Volume: 72, Issue:3 Topics: Animals; Danazol; Disease Models, Animal; Endometriosis; Endometrium; Female; Hormone Antagonists; Nandrolone; Ovary; Rats; Rats, Sprague-Dawley; RNA, Messenger; Treatment Outcome; Uterus; Vascular Endothelial Growth Factor A	2011
Dienogest inhibits aromatase and cyclooxygenase-2 expression and prostaglandin E₂ production in human endometriotic stromal cells in spheroid culture. Fertility and sterility, 2012, Volume: 97, Issue:2 Topics: Adult; Aromatase; Aromatase Inhibitors; Cells, Cultured; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; DNA; Dose-Response Relationship, Drug; Down-Regulation; Endometriosis; Enzyme-Linked Immunosorbent Assay; Female; Gene Expression Regulation, Enzymologic; Humans; Immunohistochemistry; Nandrolone; NF-kappa B; Ovarian Diseases; Ovary; Real-Time Polymerase Chain Reaction; RNA, Messenger; Spheroids, Cellular; Stromal Cells; Young Adult	2012
Dienogest. Endometriosis: still no progress. Prescrire international, 2011, Volume: 20, Issue:122 Topics: Endometriosis; Female; Humans; Nandrolone	2011
Risk factors of treatment discontinuation due to uterine bleeding in adenomyosis patients treated with dienogest. The journal of obstetrics and gynaecology research, 2012, Volume: 38, Issue:4 Topics: Adult; Endometriosis; Female; Hemoglobins; Humans; Middle Aged; Nandrolone; Proportional Hazards Models; Retrospective Studies; Risk Factors; Uterine Hemorrhage	2012
Effects of progestins on local estradiol biosynthesis and action in the Z-12 endometriotic epithelial cell line. The Journal of steroid biochemistry and molecular biology, 2012, Volume: 132, Issue:3-5 Topics: Aromatase; Cell Line; Cell Membrane; Cell Nucleus; Dydrogesterone; Endometriosis; Epithelial Cells; Estradiol; Estradiol Dehydrogenases; Estrogen Receptor alpha; Female; Gene Expression Regulation, Enzymologic; Humans; Medroxyprogesterone Acetate; Nandrolone; Progestins; Receptors, Estrogen; Receptors, G-Protein-Coupled	2012
Progestin effects on expression of AKR1C1-AKR1C3, SRD5A1 and PGR in the Z-12 endometriotic epithelial cell line. Chemico-biological interactions, 2013, Feb-25, Volume: 202, Issue:1-3 Topics: 20-Hydroxysteroid Dehydrogenases; 3-Hydroxysteroid Dehydrogenases; 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Aldo-Keto Reductase Family 1 Member C3; Cells, Cultured; Down-Regulation; Dydrogesterone; Endometriosis; Endometrium; Epithelial Cells; Estradiol Dehydrogenases; Female; Humans; Hydroxyprostaglandin Dehydrogenases; Hydroxysteroid Dehydrogenases; Medroxyprogesterone Acetate; Membrane Proteins; Nandrolone; Progesterone; Progestins; Receptors, Progesterone; RNA, Messenger	2013
[The place of therapeutic pseudopregnancy in the treatment of endometriosis]. Gazette medicale de France, 1962, Sep-10, Volume: 69 Topics: Endometriosis; Estradiol; Female; Humans; Nandrolone; Norethynodrel; Pseudopregnancy	1962
[On the management of endometriosis with ethynyl nortestosterone acetate]. Geburtshilfe und Frauenheilkunde, 1963, Volume: 23 Topics: Acetates; Endometriosis; Female; Humans; Nandrolone; Norethindrone	1963
[Oral gestagenic therapy]. Munchener medizinische Wochenschrift (1950), 1963, Aug-02, Volume: 105 Topics: Contraception; Dysmenorrhea; Endometriosis; Female; Humans; Nandrolone; Progestins	1963
[ON THE CLINICAL SIGNIFICANCE OF SYNTHETIC PROGESTEROIDS AND THEIR POSSIBLE ROLE IN CARCINOGENESIS]. Zeitschrift fur Geburtshilfe und Gynakologie, 1963, Volume: 161 Topics: Carcinogenesis; Carcinogens; Contraceptive Agents; Contraceptives, Oral; Endometriosis; Estrenes; Female; Humans; Infertility; Infertility, Female; Menorrhagia; Menstruation Disturbances; Nandrolone; Neoplasms; Progestins; Rats; Research; Toxicology	1963
[HORMONAL INHIBITION OF OVULATION. METHODS, INDICATIONS, SIDE-EFFECTS, RESULTS]. Deutsche medizinische Wochenschrift (1946), 1963, Nov-29, Volume: 88 Topics: Contraceptive Agents; Contraceptives, Oral; Dysmenorrhea; Endometriosis; Ethinyl Estradiol; Female; Humans; Infertility; Infertility, Female; Nandrolone; Ovulation; Pregnanediol; Premenstrual Syndrome; Progesterone; Progestins; Toxicology	1963
HORMONE THERAPY IN GYNAECOLOGY. The Medical journal of Australia, 1964, Nov-28, Volume: 2 Topics: Androgens; Breast Diseases; Drug Therapy; Dysmenorrhea; Endometriosis; Female; Genital Diseases, Female; Gynecology; Humans; Hydroxyprogesterones; Hypertrichosis; Infertility; Infertility, Female; Medroxyprogesterone; Menorrhagia; Mestranol; Metrorrhagia; Nandrolone; Norethindrone; Norethynodrel; Ovulation; Premenstrual Syndrome; Progesterone; Progestins; Testosterone; Uterine Neoplasms	1964
High-dose pilot study with the novel progestogen dienogestin patients with endometriosis. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2006, Volume: 22, Issue:1 Topics: Adult; Endometriosis; Female; Hormone Antagonists; Humans; Nandrolone; Pilot Projects; Statistics, Nonparametric; Treatment Outcome	2006
Dienogest inhibits BrdU uptake with G0/G1 arrest in cultured endometriotic stromal cells. Fertility and sterility, 2008, Volume: 89, Issue:5 Suppl Topics: Adult; Bromodeoxyuridine; Cell Cycle; Cell Proliferation; Cells, Cultured; Contraceptives, Oral; DNA; Drug Evaluation, Preclinical; Endometriosis; Female; G1 Phase; Humans; Nandrolone; Ovarian Diseases; Resting Phase, Cell Cycle; Stromal Cells	2008
Endometriosis and osteoporosis in practice. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1995, Volume: 85, Issue:2 Topics: Calcium Carbonate; Endometriosis; Estrogens; Female; Humans; Nandrolone; Osteoporosis; Vitamin D	1995
Endometriosis and osteoporosis in practice. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1995, Volume: 85, Issue:11 Topics: Anabolic Agents; Danazol; Endometriosis; Female; Humans; Nandrolone; Osteoporosis	1995
Animal studies on the endocrinological profile of dienogest, a novel synthetic steroid. Drugs under experimental and clinical research, 1997, Volume: 23, Issue:2 Topics: Animals; Carbonic Anhydrases; Castration; Cell Division; Contraceptives, Oral; Endometriosis; Endometrium; Enzyme Induction; Female; Hormone Antagonists; Humans; Male; Nandrolone; Ovulation; Rabbits; Rats; Receptors, Progesterone; Receptors, Steroid; Sex Hormone-Binding Globulin	1997
Effects of dienogest, a synthetic steroid, on experimental endometriosis in rats. European journal of endocrinology, 1998, Volume: 138, Issue:2 Topics: Animals; Buserelin; Cell Division; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cytotoxicity, Immunologic; Danazol; Disease Models, Animal; Endometriosis; Enzyme Inhibitors; Estradiol; Female; Immunity, Cellular; Interleukin-1; Killer Cells, Natural; Macrophages, Peritoneal; Nandrolone; Progesterone; Progesterone Congeners; Protein Kinase C; Rats; Rats, Sprague-Dawley	1998
Nandrolone decanoate causes pathologic changes in the uterus of surgically postmenopausal female cynomolgus macaques. Menopause (New York, N.Y.), 1998,Fall, Volume: 5, Issue:3 Topics: Anabolic Agents; Animals; Endometriosis; Endometrium; Estradiol; Female; Macaca fascicularis; Mammary Glands, Animal; Nandrolone; Nandrolone Decanoate; Organ Size; Ovariectomy; Postmenopause; Uterine Diseases; Uterus	1998
Endometriosis: a clinically malignant disease. European journal of obstetrics, gynecology, and reproductive biology, 1999, Volume: 82, Issue:2 Topics: Adult; Colonic Diseases; Endometriosis; Female; Hormone Antagonists; Humans; Intestinal Obstruction; Nandrolone; Rectal Diseases; Uremia; Ureteral Obstruction	1999
[Endometriosis of the lungs: analysis of diagnosis and therapy]. Ginekologia polska, 2001, Volume: 72, Issue:5 Topics: Adolescent; Antineoplastic Agents, Hormonal; Endometriosis; Female; Humans; Lung Diseases; Nandrolone; Thoracotomy	2001
Lipid metabolism during treatment of endometriosis with the progestin dienogest. Acta obstetricia et gynecologica Scandinavica, 1989, Volume: 68, Issue:7 Topics: Adolescent; Adult; Endometriosis; Female; Humans; Lipid Metabolism; Middle Aged; Nandrolone	1989
Carbohydrate metabolism during treatment of endometriosis with the progestin dienogest. Experimental and clinical endocrinology, 1989, Volume: 94, Issue:1-2 Topics: Adolescent; Adult; Blood Glucose; Endometriosis; Female; Glucose Tolerance Test; Humans; Insulin; Nandrolone; Progesterone Congeners	1989
[Behavior of parameters of liver metabolism in intermediate-term use of the gestagen dienogest in the treatment of endometriosis]. Zentralblatt fur Gynakologie, 1989, Volume: 111, Issue:12 Topics: Adolescent; Adult; Endometriosis; Female; Follow-Up Studies; Humans; Liver Function Tests; Middle Aged; Nandrolone; Progesterone Congeners; Uterine Neoplasms	1989
[Therapy of endometriosis with dienogest]. Zentralblatt fur Gynakologie, 1987, Volume: 109, Issue:12 Topics: Adolescent; Adult; Endometriosis; Female; Follow-Up Studies; Genital Neoplasms, Female; Humans; Middle Aged; Nandrolone; Progesterone Congeners	1987
[The limitations of therapy with progestational hormones]. Quaderni di clinica ostetrica e ginecologica, 1967, Dec-01, Volume: 22, Issue:12 Topics: Endometriosis; Female; Genital Diseases, Female; Humans; Hydroxyprogesterones; Menstruation Disturbances; Nandrolone; Progesterone; Progestins	1967
[Value of the estro-pgrogestative action of norsteroids in functional uterine hemorrhages]. Gynecologie pratique, 1965, Volume: 16 Topics: Adolescent; Adult; Endometriosis; Female; Humans; Leiomyoma; Middle Aged; Nandrolone; Norsteroids; Progestins; Uterine Hemorrhage; Uterine Neoplasms	1965